More recently, in January 2025, a press release was published detailing Vectura Fertin Pharma’s (VFP), a subsidiary of Philip Morris International, joint venture with a Canadian biotech firm focusing on cannabinoid-based drugs – Avicanna. According to the press release, the joint venture seeks to promote cannabis accessibility and research. Avicanna already has a stronghold in the wellness sector. However, the press release hardly makes any other mention about the involvement of Philip Morris International, but it’s clear that Big Tobacco has long had their eye in the cannabis industry.
A new survey conducted by Pew Research examined what is considered “morally acceptable” in 25 countries.…
The agency has quietly sent a CBD compliance and enforcement policy to the White House…
When renowned US film director Paul Thomas Anderson and production designer Florencia Martin visited the…
A new chapter has begun for Chilean politics. After defeating candidate Jeannette Jara in the…
What it became is one of the most consequential cannabis-related cases the Supreme Court has…
Cannabis moves fast. New strains appear every season, each promising louder flavors, bigger yields, or…